NYSE:CALX
NYSE:CALXCommunications

Does Calix's (CALX) Strong Revenue Guidance Signal Durable Competitive Momentum Ahead?

Calix, Inc. recently issued earnings guidance for its fourth quarter of 2025, projecting revenue between US$267 million and US$273 million, a midpoint that signals 2% sequential growth and 20% annual revenue expansion compared to 2024. This guidance, which reflects ongoing demand for Calix’s broadband and cloud platforms, underscores management’s confidence in near-term growth amid a competitive market landscape. With Calix’s revenue outlook now confirmed, we'll assess how stronger near-term...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

What CorMedix (CRMD)'s Dramatic Swing to Profitability and Raised Guidance Means for Shareholders

On November 12, 2025, CorMedix Inc. reported a very large year-over-year increase in third quarter revenue to US$104.28 million and net income of US$108.56 million, while also issuing net revenue guidance of US$115 million to US$135 million for the fourth quarter ending December 31, 2025. This dramatic move from a net loss to a significant net profit highlights a sharp turnaround in the company’s operational and financial performance over the past year. We’ll examine how this transformation...
NasdaqGS:CACC
NasdaqGS:CACCConsumer Finance

How Investors May Respond To Credit Acceptance (CACC) Strong Q3 Results and Aggressive Share Buybacks

Credit Acceptance Corporation reported third quarter results in the past, with revenue rising to US$582.4 million and net income reaching US$108.2 million, both higher than the previous year, alongside the completion of a significant share repurchase program totaling over 1.83 million shares since 2023. The combination of improved earnings and active buybacks may indicate both operational momentum and management's confidence in the company’s longer-term prospects. We'll examine how Credit...
NasdaqCM:ABEO
NasdaqCM:ABEOBiotechs

Abeona Therapeutics (ABEO) Is Up 17.9% After ZEVASKYN Wins Permanent J-Code and Narrows Net Loss – Has The Bull Case Changed?

Abeona Therapeutics recently reported a third-quarter 2025 net loss of US$5.16 million, a significant improvement from US$30.27 million a year earlier, as its efforts to commercialize ZEVASKYN for RDEB patients advance alongside expanded treatment center access. A pivotal development includes the Centers for Medicare and Medicaid Services establishing a permanent J-code for ZEVASKYN, poised to support broader reimbursement and access from January 2026. With a 17.90% weekly and 18.47% daily...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Catalyst Pharmaceuticals (CPRX) Is Up 6.5% After Raising Full-Year Revenue Guidance – Has The Bull Case Changed?

Earlier this month, Catalyst Pharmaceuticals reported third quarter 2025 earnings, revealing a rise in both revenue and net income year-over-year, and raised its full-year revenue guidance to between US$565 million and US$585 million. This guidance boost and continued financial progress highlight ongoing business momentum, with product demand and patient reach playing important roles in recent performance. We'll explore how Catalyst Pharmaceuticals' improved full-year revenue forecast may...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Payoneer (PAYO): Valuation Insights After 2025 Guidance Boost and Share Buyback Completion

Payoneer Global (PAYO) drew fresh investor attention after it raised its full-year 2025 guidance, signaling a more optimistic outlook for revenue and interest income in light of its latest third-quarter update and completed share buyback. See our latest analysis for Payoneer Global. Payoneer Global’s optimism has caught the market’s attention, but the stock’s momentum has struggled to keep up. Despite upbeat guidance and the completion of a sizable buyback, the 1-year total shareholder return...
NYSE:GDDY
NYSE:GDDYIT

How GoDaddy’s Raised Guidance and Buyback Activity Could Shape the Long-Term Story for GDDY Investors

GoDaddy raised its full-year 2025 revenue guidance to 8% growth and reported higher third quarter earnings and revenue versus a year ago, while also completing a share repurchase of 4.64 million shares for US$767.27 million. In a related collaboration, the ASU Student-Athlete Venture Studio spotlighted how GoDaddy Empower and the AI-powered GoDaddy Airo platform are helping student-athletes like Adama Fall build a digital presence beyond their athletic careers. Let's explore how GoDaddy's...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Did Alphabet's (GOOGL) Coral NPU and AI Partnerships Just Shift Its Edge Computing Narrative?

VeriSilicon recently announced the joint launch of the Coral NPU IP with Google, introducing an open-source, ultra-low-energy AI chip platform for edge applications like wearables and smart home devices; at the same time, Alphabet completed major multi-billion dollar bond offerings and entered new cloud and enterprise AI partnerships, notably expanding collaborations with Apple, Anthropic, and Citrix. This wave of announcements highlights Alphabet's deepening commitment to broadening its AI...
NasdaqGS:OTTR
NasdaqGS:OTTRElectric Utilities

What Otter Tail (OTTR)'s Dividend Hike and Upgraded Earnings Outlook Mean for Shareholders

On November 3, 2025, Otter Tail Corporation's board declared a quarterly dividend of US$0.525 per share, payable on December 10, 2025, and raised its full-year 2025 diluted earnings guidance to US$6.32–US$6.62 per share after announcing third-quarter results. This guidance increase signals management's confidence in operational prospects, despite a year-over-year decline in third-quarter earnings per share. We'll assess how Otter Tail's increased 2025 earnings outlook affects the company's...
NasdaqGS:WIX
NasdaqGS:WIXIT

Did Royal Mail Integration Just Shift Wix.com's (WIX) UK SME Growth Narrative?

Wix.com Ltd. recently announced that Royal Mail is now fully supported in Wix Shipping, allowing UK merchants to automate Royal Mail shipping processes directly from the Wix dashboard through its partner, Shippo. This integration streamlines fulfillment for UK businesses, potentially enhancing Wix's appeal to small and medium enterprises by providing exclusive pricing and improved operational efficiency. We'll explore how expanding automated shipping options for UK merchants could shape...
NasdaqGS:BL
NasdaqGS:BLSoftware

The Bull Case For BlackLine (BL) Could Change Following Q3 Earnings Miss, Weak Guidance and SAP Interest

BlackLine reported its third-quarter 2025 earnings, revealing revenue growth to US$178.29 million but a sharp reduction in net income and a decline in EPS, also issuing fourth-quarter and full year 2025 guidance below analyst expectations. This mixed performance comes as Engaged Capital pushes for the board to explore strategic alternatives, including a potential sale following renewed interest from SAP SE, highlighting governance and shareholder value concerns. We'll examine how BlackLine's...
NYSE:TWLO
NYSE:TWLOIT

A Look at Twilio’s (TWLO) Valuation Following Strong Results and Raised Revenue Guidance

Twilio (TWLO) has just announced a strong set of third-quarter results, with revenue climbing to $1.3 billion and a swing to profitability compared to last year. The company also lifted its annual revenue growth targets and detailed the latest round of share buybacks. See our latest analysis for Twilio. Following these upbeat quarterly results and the improved annual outlook, Twilio’s stock has enjoyed a solid run, marked by a 16.2% one-month share price return and a 27.4% gain over the past...
NYSE:HPE
NYSE:HPETech

Should HPE’s Quantum Scaling Alliance Accelerate Investor Focus on Quantum-Classical Integration?

Hewlett Packard Enterprise has announced the formation of the Quantum Scaling Alliance alongside seven leading technology organizations, aiming to accelerate the development of scalable and practical quantum computing solutions that integrate with classical high-performance computing and advanced networking. This collaborative alliance, co-led by prominent scientists and industry experts, addresses a critical challenge in bringing quantum computing to industry scale, signaling a significant...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Iovance Biotherapeutics (IOVA): Assessing Valuation After Positive Lifileucel Phase 2 Results and Earnings Update

Iovance Biotherapeutics (IOVA) has caught investors’ attention following its release of interim Phase 2 results for lifileucel in advanced nonsquamous NSCLC, which showed sustained disease control and promising response rates. The company’s recent earnings update and revenue guidance have also fueled discussion. See our latest analysis for Iovance Biotherapeutics. Iovance Biotherapeutics has been in the spotlight after unveiling positive interim data for lifileucel. Despite this clinical...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

How Investors May Respond To GlobalFoundries (GFS) Licensing TSMC GaN Technology for U.S. Power Chips

GlobalFoundries announced a technology licensing agreement with Taiwan Semiconductor Manufacturing Company Ltd. to access advanced 650V and 80V Gallium Nitride (GaN) technologies, enabling U.S.-based manufacturing of next-generation power chips for data centers, industrial, and automotive markets. This agreement is expected to help GlobalFoundries broaden its differentiated offerings and address increased demand for efficient power systems across high-growth sectors, while reinforcing U.S...